## Abstract In a limited number of cases, 14‐alkenylcodeinones (=14‐alkenyl‐7,8‐didehydro‐4,5‐epoxy‐3‐methoxy‐17‐methylmorphinan‐6‐ones) can be obtained by formic acid treatment of thevinols (=4,5‐epoxy‐3,6‐dimethoxy‐__α__,17‐dimethyl‐6,14‐ethenomorphinan‐7‐methanols), but under these conditions th
Synthesis and Characterization of New 7-Substituted 6,14-Ethenomorphinane Derivatives: N-{5-[(5α,7α)-4,5-Epoxy-3,6-dimethoxy-17-methyl-6,14-ethenomorphinan-7-yl]-1,3,4-oxadiazol-2-yl}arenamines
✍ Scribed by Serkan Yavuz; Yılmaz Yıldırır
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- German
- Weight
- 236 KB
- Volume
- 93
- Category
- Article
- ISSN
- 0018-019X
No coin nor oath required. For personal study only.
✦ Synopsis
In this study, (5a,7a)-4,5-epoxy-3,6-dimethoxy-17-methyl-6,14-ethenomorphinan-7-carboxylic acid hydrazide (5) was synthesized by the condensation of methyl (5a,7a)-4,5-epoxy-3,6-dimethoxy-17methyl-6,14-ethenomorphinan-7-carboxylate (4) with NH 2 NH 2 • H 2 O. The (5a,7a)-4,5-epoxy-3,6-dimethoxy-17-methyl-6,14-ethenomorphinan-7-carboxylic acid 2-[(arylamino)carbonyl]hydrazides 6a -6q were prepared by the reaction of 5 with corresponding substituted aryl isocyanates, and the N-{5-[(5a,7a)-4,5-epoxy-3,6-dimethoxy-17-methyl-6,14-ethenomorphinan-7-yl]-1,3,4-oxadiazol-2-yl}arenamines 7a -7q were obtained via the cyclization reaction of 6a -6q in the presence of POCl 3 . The synthesized compounds have a rigid morphine structure, including the 6,14-endo-etheno bridge and the 5-(arylamino)-1,3,4-oxadiazol-2-yl residue at C(7) adopting the (S)-configuration (7a). The structures of the compounds were confirmed by high-resolution mass spectrometry (HR-MS) and various spectroscopic methods such as FT-IR, 1 H-NMR, 13 C-NMR, APT, and 2D-NMR (HETCOR, COSY, INADEQUATE).
📜 SIMILAR VOLUMES
## Abstract magnified image A series of 3‐[(6‐chloropyridin‐3‐yl)methyl]‐6‐substituted‐6,7‐dihydro‐3__H__‐1,2,3‐triazolo[4,5‐__d__]pyrimidin‐7‐imines were designed and synthesized __via__ a multi‐step sequence using 2‐chloro‐5‐(chloromethyl)‐pyridine as the starting material. Various primary aliph